Subhranil Saha

561 total citations
102 papers, 316 citations indexed

About

Subhranil Saha is a scholar working on Complementary and alternative medicine, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Subhranil Saha has authored 102 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Complementary and alternative medicine, 13 papers in Public Health, Environmental and Occupational Health and 11 papers in Pharmacology. Recurrent topics in Subhranil Saha's work include Complementary and Alternative Medicine Studies (65 papers), Dermatology and Skin Diseases (10 papers) and Meta-analysis and systematic reviews (10 papers). Subhranil Saha is often cited by papers focused on Complementary and Alternative Medicine Studies (65 papers), Dermatology and Skin Diseases (10 papers) and Meta-analysis and systematic reviews (10 papers). Subhranil Saha collaborates with scholars based in India, Netherlands and Switzerland. Subhranil Saha's co-authors include Munmun Koley, Shubhamoy Ghosh, Aloke Kumar Ghosh, Chaturbhuja Nayak, Rajarshi Mukherjee, James Michael, Navin Singh, Mohan Giri, Anamika Basu and Jürgen Pannek and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Alternative and Complementary Medicine and Complementary Therapies in Medicine.

In The Last Decade

Subhranil Saha

86 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhranil Saha India 8 170 41 36 30 29 102 316
Munmun Koley India 8 170 1.0× 41 1.0× 35 1.0× 30 1.0× 29 1.0× 96 311
Richa Singhal India 10 131 0.8× 21 0.5× 10 0.3× 27 0.9× 17 0.6× 47 402
Antony Porcino Canada 9 117 0.7× 55 1.3× 19 0.5× 27 0.9× 15 0.5× 19 288
Stefanie Maxion‐Bergemann Germany 8 117 0.7× 40 1.0× 15 0.4× 29 1.0× 14 0.5× 20 460
Lex Rutten India 10 206 1.2× 8 0.2× 11 0.3× 19 0.6× 19 0.7× 43 309
Byungmook Lim South Korea 11 236 1.4× 45 1.1× 103 2.9× 11 0.4× 24 0.8× 37 460
E. Ernst United Kingdom 6 132 0.8× 14 0.3× 75 2.1× 11 0.4× 33 1.1× 8 344
Mandreker Bahall Trinidad and Tobago 12 205 1.2× 47 1.1× 11 0.3× 22 0.7× 10 0.3× 33 429
Andrew Feld United States 8 53 0.3× 41 1.0× 17 0.5× 24 0.8× 10 0.3× 14 337
Leonard Ho China 9 93 0.5× 39 1.0× 6 0.2× 23 0.8× 7 0.2× 27 229

Countries citing papers authored by Subhranil Saha

Since Specialization
Citations

This map shows the geographic impact of Subhranil Saha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhranil Saha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhranil Saha more than expected).

Fields of papers citing papers by Subhranil Saha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhranil Saha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhranil Saha. The network helps show where Subhranil Saha may publish in the future.

Co-authorship network of co-authors of Subhranil Saha

This figure shows the co-authorship network connecting the top 25 collaborators of Subhranil Saha. A scholar is included among the top collaborators of Subhranil Saha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhranil Saha. Subhranil Saha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosh, Shubhamoy, et al.. (2025). Individualized homeopathic medicines in the treatment of chronic tonsillitis in adults: Randomized, double-blind, placebo-controlled trial. Advances in Integrative Medicine. 12(4). 100495–100495.
2.
3.
Koley, Munmun, et al.. (2024). Efficacy of Individualized Homeopathic Medicines in the Treatment of Hemorrhoids: Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Integrative and Complementary Medicine. 30(8). 783–792.
4.
5.
6.
Ghosh, Shubhamoy, et al.. (2023). Efficacy of Individualized Homeopathic Medicines in the Treatment of Menopausal Syndrome: Double-Blind, Randomized, Placebo-Controlled Trial. Journal of Integrative and Complementary Medicine. 29(10). 649–664.
7.
8.
9.
Koley, Munmun, et al.. (2022). Individualized Homeopathic Medicines in Treatment of Vitiligo: Double-Blind, Randomized, Placebo-Controlled Pilot Trial. Journal of Integrative and Complementary Medicine. 28(1). 96–102. 2 indexed citations
10.
11.
12.
Michael, James, et al.. (2021). Individualized Homeopathic Medicines in Stage I Essential Hypertension: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial. The Journal of Alternative and Complementary Medicine. 27(6). 515–521. 4 indexed citations
13.
Manchanda, Raj Kumar, et al.. (2021). Psychometric validation of the modified Naranjo algorithm used in homeopathy for chronic cases. Journal of Complementary and Integrative Medicine. 19(1). 101–109. 2 indexed citations
14.
Ghosh, Shubhamoy, et al.. (2021). Efficacy of individualized homeopathic medicines in primary dysmenorrhea: a double-blind, randomized, placebo-controlled, clinical trial. Journal of Complementary and Integrative Medicine. 20(1). 258–267. 4 indexed citations
15.
Michael, James, et al.. (2020). Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial. Journal of Complementary and Integrative Medicine. 18(3). 599–608. 5 indexed citations
16.
Nayak, Chaturbhuja, Raj Kumar Manchanda, Anil Khurana, et al.. (2020). Clinical trials of homeopathy in urological disorders: a systematic review. Journal of Complementary and Integrative Medicine. 18(1). 23–28. 4 indexed citations
17.
18.
Saha, Subhranil, et al.. (2018). An open observational trial evaluating the role of individualised homoeopathic medicines in the management of nocturnal enuresis. Indian Journal of Research in Homoeopathy. 12(3). 149–149. 3 indexed citations
19.
Saha, Subhranil, et al.. (2015). Obstetrics and gynecology outpatient scenario of an Indian homeopathic hospital: A prospective, research-targeted study. Journal of Traditional and Complementary Medicine. 6(2). 168–171. 3 indexed citations
20.
Saha, Subhranil & Munmun Koley. (2013). HOMEOPATHIC TREATMENT OF HEADACHES AND MIGRAINE: A META-ANALYSIS OF THE RANDOMIZED CONTROLLED TRIALS. Asian Journal of Pharmaceutical and Clinical Research. 6(7). 194–199. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Munmun Koley Breakdown of academic impact, for papers by Richa Singhal Breakdown of academic impact, for papers by Antony Porcino Breakdown of academic impact, for papers by Stefanie Maxion‐Bergemann Breakdown of academic impact, for papers by Lex Rutten Breakdown of academic impact, for papers by Byungmook Lim Breakdown of academic impact, for papers by E. Ernst Breakdown of academic impact, for papers by Mandreker Bahall Breakdown of academic impact, for papers by Andrew Feld Breakdown of academic impact, for papers by Leonard Ho
Rankless by CCL
2026